Fulgent Genetics Goodwill

Fulgent Genetics (FLGT) currently reports a goodwill of $54M as of June 2026. That compares with $22M in the prior-year period — up 144.2% year over year. Use the charts on this page to explore Fulgent Genetics's goodwill history and peer comparisons.

Fulgent Genetics's goodwill increased from $22M to $54M — a 144.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Fulgent Genetics reported $54M in goodwill as of June 2026. That compares with $22M in the prior-year period — up 144.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $54M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fulgent Genetics, and consider following FLGT for alerts when major investors trade the stock.

Fulgent Genetics is classified in the Healthcare sector. On goodwill, it currently shows $54M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FLGT with unrelated industries.